"Talk to your cardiologist." That's the advice offered last week by Wills Eye Institute, a hospital specializing in eye care, following a JAMA article linking aspirin therapy to macular degeneration.

The Food and Drug Administration has approved what it called the first drug to treat an eye condition that can interfere with the part of the retina responsible for reading vision.

A panel of Food and Drug Administration experts is recommending the approval of a drug made by Genentech for diabetic macular edema, the company said.

EyeScience Labs on Wednesday introduced a new eye vitamin for people with diabetes.

Valeant Pharmaceuticals is set to acquire a privately owned ophthalmic biotechnology company, the drug maker said Monday.

A large European study released Tuesday found that daily aspirin use is linked to an increased risk of age-related macular degeneration, a disease that can damage the central vision that is essential for reading and driving.

A volunteer eye health and safety organization has introduced a new program that seeks to educate the public on the potential effects diabetes may have on one's vision.

Kerr Drug is offering savings of up to 70% to customers who buy prescription eyewear through a new website, the chain said Wednesday.

EyeScience on Thursday introduced a new eye vitamin for those who spend their work day staring at a computer screen in an effort to help prevent and alleviate vision problems associated with computer vision syndrome.

Fera Pharmaceuticals has launched an ocular bacterial infections treatment.

Watson Pharmaceuticals has filed a regulatory approval application with the Food and Drug Administration for a generic drug for eye disease, the company said Tuesday.